Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase.
about
Trovafloxacin enhances lipopolysaccharide-stimulated production of tumor necrosis factor-α by macrophages: role of the DNA damage response.Resveratrol mitigates lipopolysaccharide-mediated acute inflammation in rats by inhibiting the TLR4/NF-κBp65/MAPKs signaling cascade.Co-culture of Hepatocytes and Kupffer Cells as an In Vitro Model of Inflammation and Drug-Induced Hepatotoxicity.Endoplasmic Reticulum Stress Induction and ERK1/2 Activation Contribute to Nefazodone-Induced Toxicity in Hepatic Cells.
P2860
Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trovafloxacin potentiation of ...... e and c-Jun N-Terminal Kinase.
@en
Trovafloxacin potentiation of ...... e and c-Jun N-Terminal Kinase.
@nl
type
label
Trovafloxacin potentiation of ...... e and c-Jun N-Terminal Kinase.
@en
Trovafloxacin potentiation of ...... e and c-Jun N-Terminal Kinase.
@nl
prefLabel
Trovafloxacin potentiation of ...... e and c-Jun N-Terminal Kinase.
@en
Trovafloxacin potentiation of ...... e and c-Jun N-Terminal Kinase.
@nl
P2093
P2860
P356
P1476
Trovafloxacin potentiation of ...... e and c-Jun N-Terminal Kinase.
@en
P2093
Patricia E Ganey
Robert A Roth
Ryan P Albee
P2860
P304
P356
10.1124/JPET.113.211276
P407
P577
2014-02-13T00:00:00Z